Cue Biopharma
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.05 | -6.97 | -5.93 | -5.97 | -4.41 | -3.65 | -3.30 | -1.07 | -2.68 | -0.29 | -2.28 | -4.57 | -7.89 | |
| 0.55 | 0.54 | 0.51 | 0.52 | 0.51 | -0.10 | 0.36 | 0.25 | 0.18 | 0.40 | 0.12 | 0.01 | 0.42 | |
| 1.34 | 1.32 | 1.18 | 1.05 | 0.93 | 0.63 | 0.54 | 0.40 | 0.46 | 0.17 | 0.01 | 3.76 | 4.10 | |
| 0.16 | -0.41 | -0.17 | -1.48 | -0.74 | -0.36 | 0.74 | 0.93 | -1.08 | -1.21 | -1.40 | 2.62 | 0.29 | |
| 0.00 | 0.00 | 0.03 | 0.01 | 0.00 | 0.00 | 0.06 | 0.01 | 0.00 | 0.00 | 0.03 | 0.00 | 0.02 | |
| 3.24 | – | -0.03 | -0.01 | 0.06 | 0.00 | -0.06 | -0.01 | -2.01 | 1.91 | -0.03 | – | – | |
| – | – | – | – | -0.59 | -0.40 | -0.40 | -0.31 | -0.30 | -0.41 | 0.00 | 0.00 | -0.39 | |
| 2.97 | 3.04 | 1.43 | -0.60 | 5.75 | -0.38 | -0.40 | 5.59 | 0.00 | 2.58 | 0.06 | 4.73 | 6.28 | |
| 1.16 | -3.93 | -4.54 | -6.58 | 1.40 | -4.03 | -3.77 | 4.51 | -4.70 | 4.19 | -2.24 | 0.16 | -1.59 | |
| -5.05 | -6.97 | -5.97 | -5.98 | -4.41 | -3.65 | -3.36 | -1.08 | -2.68 | -0.29 | -2.30 | -4.57 | -7.91 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.